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Abstract 
This paper describes a new combined impedance plethysmographic 
(IPG) and electrical bioimpedance spectroscopic (BIS) instrument 
and software that allows noninvasive real-time measurement of 
segmental blood flow and changes in intracellular, interstitial, and 
intravascular volumes during various fluid management 
procedures. The impedance device can be operated either as a 
fixed frequency IPG for the quantification of segmental blood flow 
and hemodynamics or as a multi-frequency BIS for the recording of 
intracellular and extracellular resistances at 40 discrete input 
frequencies. The extracellular volume is then deconvoluted to 
obtain its intra-vascular and interstitial component volumes as 
functions of elapsed time. The purpose of this paper is to describe 
this instrumentation and to demonstrate the information that can 
be obtained by using it to monitor segmental compartment 
volumes and circulatory responses of end stage renal disease 
patients during acute hemodialysis. Such information may prove 
valuable in the diagnosis and management of rapid changes in the 
body fluid balance and various clinical treatments. 
 
Keywords: Bioimpedance, plethysmograph, spectroscopy, 
compartment volumes, blood flow 
 
 
Introduction 
Hemodynamic redistribution of fluids between body 
segments and between the intracellular and extracellular 
compartments within those segments are often of central 
importance to various fluid management procedures [1,2], 
disease states [3-6] and orthostatic dysfunction [7,8]. These 
redistributions affect cardiovascular function, water balance 
and perhaps skeletal muscle function through physiological 
mechanisms that may be better understood with simultane-
ous characterization of both the extent and rate of the inter-
compartment redistributions that take place during fluid 
management therapy.  
Objective methods to monitor such factors include tracer 
dilution techniques, which are invasive, time consuming, and 
expensive, and cannot be repeated in the short intervals 
that are required to follow events over the usual time course 
of interest. Bioelectric impedance instrumentation may be 
used to monitor these changes in the body and may be a 
valuable aid in clinical diagnosis and research. 
Two different types of bioelectric impedance instruments 
are available. Fixed frequency bioelectrical impedance 
plethysmographic (IPG) techniques are valuable noninvasive 
tools that provide information about overall segmental 
volumes, blood flows, and hemodynamic status with a high 
degree of temporal resolution [9-12]. The second type, 
electrical bioimpedance spectroscopy (BIS) [13,14] is a multi-
frequency technique that, when coupled with computer-
aided equivalent circuit analysis, may be used to provide 
information about relative redistributions of fluids between 
the intra-and extracellular compartments of the monitored 
segments. 
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Tissues are ionic conductors of electric current, which by 
virtue of their structural heterogeneity, exhibit dielectric 
relaxation phenomena that give rise to frequency dependent 
variations of the impedance to such conduction [15]. In the 1 
- 150 kHz range, the resultant dielectric dispersions arise 
principally from the capacitive reactances of cell mem-
branes. At low frequencies in this range, high cell membrane 
reactances prohibit current flux through cells, so that tissular 
impedance is governed by properties of the extracellular 
fluid. At high frequencies, membrane reactance is negligible, 
allowing current to pass through both the extra- and 
intracellular spaces. Tissular impedance is then governed by 
the combined properties of the two compartments. Time 
series of tissue impedances measured as a function of 
frequency consequently embody tissue structural informa-
tion that can illuminate changes in the relative distributions 
of fluids between the tissular intra- and extracellular com-
partments [16-19]. 
Various resistance/capacitance (R/C) models [15,16, 
20,21] are used to quantify segmental volumes from 
recorded impedance measurements. The R/C model that is 
used by most currently available impedance systems (Figure 
1) represents the tissue as two parallel conductance paths; 
one through an extracellular compartment having average 
resistance (Re), and the other through an intracellular 
compartment having average resistance (Ri ) and capaci-
tance (Cm). This model, which is limited to the determination 
of “intracellular” and “extracellular” resistances (Ri and Re, 
respectively), can therefore only be used to estimate the 
corresponding intracellular, extracellular, and overall 
monitored segment volumes. 
 
 
Figure 1: General equivalent circuit model of current 
conduction through tissue. 
  
Unfortunately, an issue of principal concern in most 
clinical contexts is how the “extracellular volume” is 
distributed between its interstitial and intravascular 
compartments; an issue that the two component R/C 
models cannot address. We have developed a more complex 
model to remedy this deficiency. 
This study will describe a new analytical procedure that 
uses BIS data to obtain quantitative values of intracellular, 
interstitial, and intravascular volume changes and relative 
transfer of fluids between these compartments of a given 
body segment. Potential applications of this capability in the 
clinical environment include monitoring of the hydration 
status of patients during surgery, during dialysis, or while in 
the intensive care unit, and of highly premature infants. It 
can also be used to investigate chronic fatigue syndrome and 
other disease states that involve autonomic impairment of 
the cardiovascular system. 
 
Background 
A major component of our analytical procedure is the 
development and application of a more complex equivalent 
circuit model [22-24], illustrated in Figure 2A, which can be 
used to calculate the interstitial and intravascular compart-
ment volumes that comprise the previously calculated 
“extracellular” volume. 
The extravascular soft tissue compartment of the 
monitored segment is then represented in our model as a 
cylindrical homogeneous suspension of identical oblate 
spheroidal cells with long axes, a, oriented parallel to the 
applied field, I, as shown in Figure 2B.  Cells are allowed to 
change volume only through variation in minor axis, b. The 
cell volume fraction and the intracellular and extracellular 
conductivities of this compartment are related to the 
compartment’s Re, Ri, and Cm in Figure 1 with theory 
developed by Hugo Fricke [25-29]. 
 
 
 
Figure 2A: Equivalent Circuit Diagram used in EIS Analysis for 
Intracellular, Interstitial, and Intravascular Volumes. 
 
 
 
Figure 2B: Extra-vascular soft tissue compartment of EIS model. 
 
Our model is based on an assumed physical structure of 
the monitored segment; particularly its extravascular 
compartment (Figure 2A); which governs the values and 
frequency dependence of the “resistive” and “reactive” 
components of the segmental impedance. The model is fit to 
each measured spectrum by an iterative numerical process 
in which values of the model parameters are found that 
bring model-prescribed spectra into closest possible 
agreement with the measured spectrum.  
Re
Rblood 
Ri            Cm 
Rbone 
b 
a 
I
 
 
Montgomery et al.: A system to monitor segmental changes during hemodialysis. J Electr Bioimp, 8, 40-53, 2017 
42 
 
Because the model is a function of more parameters 
than are uniquely determined by information in an 
impedance spectrum, selected model parameters must be 
assigned “fixed” values in the fitting process.  
 
Materials and methods 
Device description 
The Z-Spec-2, (UFI Inc., Morro Bay, CA) combines two 
bioimpedance instruments into a single device. It combines a 
fixed frequency impedance plethysmograph (IPG) and a 
multi-frequency electrical bioimpedance spectrograph into 
one unit. The IPG mode is used to quantify segmental blood 
flow and total segmental conductive volume. The BIS mode 
is used to monitor segmental intracellular and extracellular 
compartment volumes as is done by other BIS devices. 
However, our proprietary software also allows the Z-Spec-2 
to divide the extracellular compartment volume into its 
intravascular and interstitial components.  
The current Z-Spec-2 design, shown in Figure 3, is a 
unique bioimpedance measurement device that supplies 
subject tissue impedance while "sweeping" across 40 
discrete excitation frequencies over a wide frequency range 
when functioning as a BIS for compartment volume 
measurements. The Z-Spec-2 can be paused at 50 kHz to 
function as a fixed frequency IPG for blood flow 
measurements.   
The Z-Spec-2 provides a “scheduler” capability that can 
be used to operate the instrument continuously as either an 
IPG or an BIS or any desired time sequenced combination of 
the two modes. 
The Z-Spec-2 includes a Lead I electrocardiographic (ECG) 
and a photoelectric plethysmographic (PPG) analog channel 
(via external transducers) which provide measures that are 
used to quantify segmental blood flow.  
A built-in 16 bit microcontroller is responsible for 
management of all Z-Spec-2 functions. 
Figure 4 shows the basic functional block diagram of our 
Z-Spec-2 EIS/IPG instrumentation. 
 
Z-Spec-2 design features 
The Z-Spec-2 final design has the following features:  
1) Combines both BIS (Z-Spec-2) and IPG (Fixed Frequency) 
capability in a single device using the current BIS 
enclosure. Includes the current BIS Function and 
Circuitry. A "Pulsatile Size" switch is included on front 
panel for the IPG function.  
2) Operates from an isolated power supply with either an 
in-line or wall-mount transformer for power from a 
120V 60Hz AC power source (with no battery power).   
3) Front panel includes an LCD display that shows real-time 
plots of ECG, photoelectric pulse signals (switch 
selectable) and Delta-Ro signals.  
 
4) The software includes the current level and 
resistance/reactance values at each frequency.  The 
software also includes an added Pulsatile Module that 
saves time segments of Pulsatile data as separate ASCII 
files. The software allows recording BIS, IPG, or a 
scheduled (software settable) combination of the two. 
The PC Software is designed and tested to operate 
under Windows 2000 and Windows XP operating 
systems, and support unit operation via either RS232 or 
USB interfaces under each of these operating systems.   
5) The system includes internal signal conditioning and A-D 
conversion capability for ECG and photoelectric pulse 
(from UFI 1020) channels. ECG and photoelectric 
channels have variable size controls located on the front 
panel.   
6) Instrument calibration factors are stored within the 
instrument to enable the use of generic support/ 
interface software on all similar BIS units. 
 
Application 
The application and capability of the BIS when operated in 
the IPG mode to quantify segmental blood flow and 
hemodynamics is described elsewhere (4,6). Details of the 
analytical algorithm used to derive individual fluid compart-
ment volumes from the impedance spectroscopic recordings 
are given in previous articles [30-32].  
We hypothesize that this new instrument will be able to 
quantify changes in the three fluid compartments as fluid 
volume is removed during hemodialysis.  We therefore, 
aimed to evaluate the changes in the three volume 
compartments (intravascular, interstitial, and intracellular), 
and hemodynamic patterns associated with fluid volume 
removal during dialysis. 
 
Equipment validation 
Hemodialysis treatment sessions provide ideal opportunities 
to monitor exogenously induced inter-compartmental fluid 
shifts with minimal additional procedures. If the BIS net 
volume changes we compute do indeed provide a way to 
track three compartment fluid shifts, then such BIS-recorded 
fluid shifts should correlate with those of an independent 
physiologic measure of fluid volume changes.   
The hemodialysis (HD) patient’s hematocrit (HCT), 
expressed as %, rises (due to hemoconcentration) as excess 
fluids are removed by ultra-filtration (UF) – and falls or rises 
more slowly (due to hemodilution) as extravascular fluid 
moves into the vascular system as a result of compensatory 
osmotic and hydrodynamic pressure changes. Both changes 
in HCT and changes in the rate of vascular “refill” can be 
measured noninvasively during routine HD therapy sessions. 
Changes in HCT can be measured by a CritLine® optical 
monitor (HemaMetrics, Kaysville, UT).  The rate of “refill” 
can be calculated from the BIS volume data.   
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Figure 3: Prototype Z-Spec-2 IPG/EIS system (shown with control/data recording laptop and Arc Simulator unit). 
 
 
 
 
Figure 4: Z-Spec-2 functional block diagram. 
 
A CritLine® optical monitor served as the “gold standard” 
for validation and was used simultaneously to detect on-line 
changes in hematocrit. The CritLine® measures the optical 
absorption and scattering properties of red blood cells as 
they pass through the HD circuit.   Since red blood cell mass 
and hemoglobin do not usually change during treatment, the 
relative changes in hematocrit should parallel the changes in 
blood fluid content. The CritLine® instrument is well 
validated [33,34], FDA-approved [35,36], and routinely used 
for patient management.  
Validation was previously performed in 60 End Stage 
Renal Disease patients during chronic treatment session by 
analyzing the time profiles of fluid redistribution, obtained 
from the BIS data during hemodialysis, to mathematically 
derive post hoc hematocrit profiles. These profiles were 
then compared to the simultaneously measured hematocrit 
values recorded independently using the CritLine® monitor. 
Regression and Bland Altman analyses were used to 
compare the BIS data and CritLine® hematocrits at sequential 
times during the 60 chronic HD sessions with the patients in 
a horizontal position.  The statistical and graphical evidence 
obtained [31] confirmed that the BIS system reliably 
monitors the continuous and real time rates of change of the 
fluid volumes of the three compartments in the chronic 
treatment setting.  
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However, it has been shown that the fluid responses in 
the intracellular, interstitial and intravascular compartments 
may differ during the acute and chronic HD sessions [37]. 
It was therefore necessary to replicate the earlier 
validation procedures using the bioimpedance data from the 
22 end stage kidney disease (ESKD) patients that took part in 
this study. 
 
Statistics 
Statistical analysis was performed using MedCalc Ver. 
10.0.0.0.  A Student’s t test was used to compare paired 
observations.  Pearson’s correlation (38) and Bland-Altman 
(39) analyses were used to compare the BIS hematocrit 
(BISHCT) and  the CritLine® hematocrit (CLHCT) results at 
each time point.  Results are reported as mean ± SD.  
 
Validation of BIS used during acute HD treatment  
The institutional review board approved protocol allowed 
BIS measurement in consented adult ESKD patients receiving 
dialysis in an acute dialysis unit.  Patients with the following 
conditions were excluded from the study: irregular 
heartbeat, unstable angina, active gastrointestinal bleeding, 
pregnancy, poor peripheral circulation, skin conditions such 
as psoriasis, damaged nerves in the arms or legs, liver 
failure, cancer, collagen vascular disease such as lupus, 
chronic swelling of the arms or legs due to obstruction of the 
lymph or blood vessels, implanted pacemaker, or other 
implanted electrical device, overactive thyroid disease, or 
chronic substance abuse. Studies were performed in 
patients who were resting in the supine position for at least 
2 hours before obtaining measurements.  
All patients were treated with Cobe Century hemodia-
lysis machine and Polyflux 170H dialyzer. Dialysis fluid 
sodium concentration (140 mEq/L) and ultrafiltration rate 
(UFR) were kept constant throughout the treatment. Blood 
flow rate, dialysis fluid flow rate, treatment time, and total 
volume removed were ordered by the Attending physician 
according to the patient’s requirement.        
Blood Pressure (BP) and heart rate (HR) were measured 
and recorded by a technician immediately before dialysis, 
every 15 minutes throughout the treatment, and at the end 
of treatment. Signs and symptoms related to hypotension 
and dialysis complications were recorded.  All patients were 
treated in the supine position.   
Hematocrit (HCT), an indirect measure of blood volume 
(BV), was continuously monitored on-line using CritLine®-
TQA (Hema-Metrics, Kaysville, UT). Percent change in BV 
(%BV) during HD was determined from the % variation of 
HCT. 
A bioelectric impedance spectroscopic system (LDM, San 
Jose, CA and UFI, Inc., Morro Bay, CA) was used to obtain 
periodic, noninvasive relative measurements of intracellular 
(Vc), interstitial (Vi), and intravascular (Vb) volumes, 
segmental blood flow and hemodynamic properties during 
dialysis. Compartment volume results were displayed in real 
time, while blood flow and hemodynamic properties were 
computed in post-session analyses. Changes in interstitial 
and intravascular volumes from the BIS recordings were 
used to calculate the HCT-time profile for each patient.. 
 
 
Figure 5: Electrode placement. 
 
The BIS instrument was attached to the subject’s 
dominant lower leg. The source electrodes were placed just 
above the knee, and just above the malleolus, laterally. The 
sampling electrodes were placed just below the knee and 
above the ankle, medially. Figure 5 shows electrode 
placement on the calf.  
All dialysis sessions included in this analysis lasted at 
least 120 minutes. Shortly after 120 minutes some of the 
dialysis sessions were terminated for different reasons; 
patients experiencing syncope, cramps, completion of the 
required dialysis, etc. Mean calculated BIS and observed 
CritLine® hematocrit (± SD) values are presented in Table 1 
for elapsed dialysis times of 30, 60, 90, 120, and END. The 
END values that are given in Table 1 were taken from the 
last minute before cessation of dialysis. The average ( ±  SD) 
time for the END data is 171.2 ± 21.7 min. from the start of 
dialysis. The CritLine® hematocrit values measured by the 
optical sensor in Table 1 and the following tables and figures 
are designated CLHCT.  The values calculated from the BIS 
measurements are designated by BISHCT. No significant 
differences were found between the BISHCT and the CLHCT 
values at any of the elapsed times listed in Table 1. 
Results of the regression and Bland Altman analyses, at 
each of the elapsed times, are listed in Table 1. Graphical 
results of the regression and Bland Altman analyses at the 
specified elapsed times are given in Figures 6A and 6B, 
respectively.   
Source 
Source 
Sampling 
Sampling 
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Table 1.  BIS and CritLine Hematocrit values ± SD at specified elapsed times during dialysis. 
ELAPSED TIME 
(min) 
N BISHCT 
(%) 
BISHCT SD CLHCT 
(%) 
CLHCT SD 
30 22 31.91 4.68 31.91 4.68 
60 22 32.14 4.73 32.12 4.71 
90 22 32.36 4.73 32.32 4.67 
120 22 32.52 4.71 32.59 4.68 
End 22 33.06 4.96 33.09 4.96 
 
 
The regression equation and R2 value for BISHCT vs. 
CLHCT are given in Figure 6A. The solid trace in Figure 6A 
represents the corresponding regression equation. The 
BISHCT/CLHCT points included in the Bland Altman analysis 
for each time period are represented as: 30 min. are open 
circles, 60 min. are solid squares, 90 min. are solid circles, 
120 min. are open triangles, and the END values are open 
squares. 
Table 2 lists the corresponding Bland Altman results. 
  
 
 
Table 2. Differences ± SD, limits of agreement, and independent t-test probabilities of significance between 
BISHCT and CLHCT values at specified elapsed times during dialysis.  
ELAPSED TIME 
(min) 
Difference with CLHCT Limits of agreement 
(mean ± 1.96SD) 
P  
(by non-pair t-test) 
30 -0.00692 ± 0.0318 -0.0692 ± 0.0799 0.996 
60 -0.01166 ± 0.1393 -0.2847 ± 0.3686 0.993 
90 - 0.03235 ± 0.2469 -0.5163 ± 0.6415 0.982 
120 0.06657 ± 0.2492 -0.4218 ± 0.7467 0.962 
END 0.03746 ± 0.1590 -0.2742 ± 0.4715 0.980 
 
 
 
Figure 6A: Linear regression and Bland Altman analyses comparing the 
BISHCT and CLHCT results at specified times during dialysis. 
 
These regression and Bland Altman analyses confirm that 
the BIS algorithm can be used to reliably derive the continu-
ous and real time rates of change of the intra-cellular, 
interstitial, and intravascular compartmental fluid volumes 
in both acute and chronic ESKD patients. 
Regression results yielded a R2  > 0.99 between the two 
measures of hematocrit at different times during dialysis. 
The slopes of the regression equations at the different times 
were nearly identical, demonstrating an almost one to one 
correspondence between the calculated BIS and the 
measured CritLine® hematocrits. 
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Figure 6B: Bland Altman analysis. The BISHCT/CLHCT points included 
above for each time period are represented as: 30 min. are open 
circles, 60 min. are solid squares, 90 min. are solid circles, 120 min. are 
open triangles, and the END values are open squares. 
 
Bland Altman analyses show that the BIS algorithm can 
be used interchangeably with the CritLine® monitor for the 
measurement of hematocrit. In addition, it also shows that 
the calculated volume changes can then be used to derive 
other variables that can provide valuable insight into the 
various fluid responses that take place during fluid 
management therapy.  
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Dialysis Demonstration 
The intracellular, interstitial and intravascular volume 
changes that were calculated from the series of HD sessions 
used in the above validation study are given in Figures 7A, B 
and C, respectively below. Figure 7 shows that the three 
component volumes of the acute patients undergoing HD 
varied widely among the individual patients. This finding 
may, in part, be attributed to the differences in the progres-
sion of ESKD and other accompanying diseases of the various 
patients. The patients monitored during these acute HD 
sessions were in the hospital for treatment of a number of 
disease states and/or complications of their kidneys. As 
such, they may have been given HD for the first time in our 
facility without knowledge as to their responses during 
previous HD treatments. 
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Figure 7A: Individual patient intracellular volume changes during 
dialysis vs elapsed time.  
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Figure 7B: Individual patient interstitial volume changes 
during dialysis vs elapsed time.  
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Figure 7C: Individual patient intravascular volume changes 
during dialysis vs elapsed time.  
 
Due to the observed variance of the individual patients, 
each patient had to be considered as a specific case for HD 
treatment. Use of the BIS system, described herein, would 
greatly facilitate administration of HD in the acute patients 
or in those patients being treated during their initial fluid 
management therapy.  
To demonstrate the capability of the ZSpec-2 to provide 
information regarding fluid compartment volume and 
circulatory changes for individual patients during HD we 
provide the results of two very different patients below. The 
results of BIS and CritLine® along with simultaneous BP and 
hemodynamic (blood flow) measurements were obtained in 
the two ESKD patients:  
 
1) Patient Type A, a 57-yr old male with long-standing 
hypertension and past medical history of congestive 
heart failure and  
 
2) Patient Type B, a 26 year old male with long-standing 
type-1 diabetes mellitus complicated by severe diabetic 
autonomic neuropathy, diabetic retinopathy, and 
diabetic nephropathy.  
 
Prior to dialysis, both patients had no overt signs of 
congestive heart failure or fluid overload and showed 
comparable pre-dialysis BP. As shown in Figures 8A and 8B 
the ultrafiltration (UF) rates were similar, e.g. 1.0-1.3 L/hr 
and the total amount of fluid removed during dialysis was 
the same for both patients. 
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Figure 8A: Patient Type  A's -  UF rate and amount removed vs. elapsed 
time. 
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Figure 8B: Patient Type  B's -  UF Rate an Amount Removed vs. 
elapsed time. 
  
Figures 9A and 9B illustrate the change in the CritLine® 
HCT and the corresponding HCT calculated from the BIS data 
for the Type A and B patients, respectively. The HCT for the 
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Type A patient increased from 24% to approximately 27% 
during dialysis. That of Type B increased from ~37.5% to 
39%. The extent of agreement between the CritLine® 
measured HCT and that of the calculated values for both 
patients show that the algorithms used to derive the three 
fluid compartment volumes may be used for both chronic 
and acute patients during dialysis. 
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Figure 9A: Measured and predicted HCT values for Patient Type A 
vs. elapsed time. 
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Figure 9B: Measured and predicted HCT values for Patient Type B 
vs. elapsed time. 
 
Results 
Compartment volume changes calculated from multi-
frequency recordings 
Figures 10A and 10B depict the volume changes of the 
intracellular, interstitial and intravascular fluid compart-
ments of the Type A & B patients, respectively. HD in the 
Type A patient with minimal BV change was accompanied by 
removal of a large volume of fluid from the interstitial space 
and an increase in cellular volume. HD in the Type B patient 
with marked decrease in BV was accompanied by minimal 
net changes in both the interstitial and cellular volumes.  
The fluid removed from the Type A patient appears to be  
primarily from the extravascular (Vb and Vi) space. Whereas, 
fluid removed from the Type B patient was mainly from the 
vascular space, leading to symptoms of low blood pressure 
and dizziness. 
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Figure 10A: Patient Type A's  segmental and compartment volume 
changes vs. elapsed time. 
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Figure 10B: Patient Type B's total segmental and compartment 
volume changes vs. elapsed time.  
 
Subject A’s BP remained stable throughout the entire HD 
session with practically the same UF rate of about 1 L/hr.    
Hence, there was no intradialytic hypotension (IDH) 
However, the decline in vascular volume during HD was 
temporally accompanied by a proportionate decrease in 
interstitial volume. This suggests that a proportionate 
amount of vascular refilling occurred, which may have 
prevented the development of IDH (Figure 10A).  
Figure 10B shows that Patient B had a progressive 
decline in vascular volume, which reached its climax toward 
the end (130-180 min) of the HD session, while both 
interstitial and cellular volumes remained relatively stable. In 
Patient B an IDH episode was noted near the end of dialysis 
session when the same UF rate of about 1 L/hr was applied.  
This hypotensive response is consistent with his impaired 
autonomic function.  
The individual compartment volumes are then used to 
provide a measure of outflow or “refill” from the extra-
vascular (XV) space into the vascular system during dialysis. 
In patient Type A, XV fluid moved to refill the intravascular 
space, Figure 11A. Whereas in patient Type B, not much fluid 
was transferred from the XV space into the vascular system 
resulting in hypotension and symptoms of dizziness, Figure 
11B. 
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Figure 11A: Patient Type A's intravascular and extravascular 
volume changes vs. elapsed time. 
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Figure 11B: Patient Type B's intravascular and extravascular 
volume changes vs. elapsed time. 
 
Segmental blood pressures, blood flow, and vascular state 
calculated from hand recorded blood pressures and fixed 
frequency impedance data   
The following results were obtained from the hand recorded 
blood pressures and the output of the bioimpedance 
instrument when it was operated in its fixed frequency 
mode with a constant input current of 50 kHz and the 
pulsatile waveforms recorded for a period of 60 seconds. 
The parameter values provided below were calculated using 
the Rheosys computer program [16] and are mainly 
dependent upon the morphology and shape of the recorded 
pulsatile waveforms. 
  
Blood pressure 
Figure 12A shows that the systolic BP of the Type A patient 
remains relatively stable, dropping about 15 mmHg during 
dialysis.  
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Figure 12A: Patient A and B's systolic blood pressure vs. elapsed 
time. 
The systolic blood pressure of the Type B patient 
dropped about 55 mmHg during the total dialysis 
treatment, which included a 45 mmHg during the last 
hour of dialysis.  Note that the large decrease in Type 
B's systolic blood pressure started at approximately 
125 min elapsed time. This time was the period in 
dialysis at which the maximum amount of fluid was 
removed from the intravascular compartment (Figure 
11B). 
Figure 12B shows that the diastolic BP of the two 
patients experience decrease at the same points in elapsed 
time. Type B's diastolic blood pressure decreased approxi-
mately 30 mmHg and that of Type A decreased ~10 mmHg. 
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Figure 12B: Patient Type   A and B's diastolic blood pressure vs. 
elapsed time. 
 
Figure 12C illustrates the mean arterial pressure = 
diastolic + 1/3(pulse pressure) that results from the blood 
pressure responses displayed above.  MAP decreased from  
~ 125 mmHg to ~85 mmHg for Type B and remained 
relatively constant for Type A, decreasing approximately 10 
mmHg during the last period of dialysis. 
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Figure 12C: Patient Type  A and B's mean arterial blood pressure 
vs. elapsed time. 
 
Segmental Blood Flow 
The following results compare the changes in heart rate 
(Figure 13A), maximum pulse amplitude (Figure 13B) and 
resulting calf blood flow (Figure 13C) for Patients A and B 
during dialysis.  
One potential contributing factor to Patient B's 
responses may be the observation that the various physio-
logic mechanisms that normally respond to minimize 
hypotension are inactive or become fatigued during dialysis 
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of ESKD patients who exhibit serious complications or 
advanced kidney disease. Also, the various parameters that 
are displayed tend to become less effective after 
approximately 125 - 150 minutes elapsed time during which 
the compartment volumes experienced their maximum fluid 
removal. 
These results were obtained even though both patients 
had the same relative UF rate and similar amounts of total 
fluid withdrawn. The Type B patient had several conditions 
that may have altered or influenced his 
autonomic/sympathetic responses to dialysis. The Type A 
patient did not have (at the time of study) any complications 
that might alter his natural responses to dialysis. 
Heart rate (BPM - Figure 13A) was calculated from time 
between subsequent QRS peaks of the recorded ECG 
waveforms. The heart rate of both patients increased during 
dialysis. Patient A's heart rate increase from approximately 
75 BPM to 90 BPM during dialysis while that of patient B 
only increased about 5 BPM. 
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Figure 13A: Patient Type A and B's heart rate vs. elapsed time. 
 
The maximum pulse amplitude (Amp) for each patient 
(Figure 13B) was taken from the maximum height of the 
systolic portion of the bioimpedance waveform when 
converted to ohms resistance. Amp increased for the Type A 
patient and decreased slightly for the Type B patient. 
The heart rate and pulse amplitude responses above 
yield an increase in calf blood flow (ml/100ml/min) for Type 
A and a decrease of ~ 50% for Type B between 25 and 100 
min of dialysis as shown in Figure 13C.   
 
Pulse Transit Time and Peripheral Resistance 
Pulse Transit Time (PTT - sec, Figure 14A) is the time interval 
between the ECG QRS complex and the start of the 
bioimpedance pulse waveform. PTT remains constant for 
Type A and increases markedly for Type B starting about 125 
min elapsed time. This PTT increase indicates that the 
systemic circulation of the Type B patient dilated extensively 
starting at approximately 125 min elapsed time. 
Peripheral resistance (PR, Figure 14B) is defined as 
MAP/%BF (where BF is in units of ML/100 ML/Min).  PR 
remained constant during the Type A patient dialysis but 
increased dramatically twice during the Type B patient 
dialysis. 
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Figure 13B:  Patient Type A and B’s maximum blood pulse 
amplitude vs. elapsed time. 
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Figure 13C:  Patient Type A and B’s calf blood flow vs. elapsed 
time. 
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Figure 14A: Patient Type A and B’s pulse transit time vs. elapsed 
time. 
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Figure 14B:  Patient Type A and B’s peripheral resistance vs. elapsed time. 
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In the Type A patient, PR remained relatively stable in 
association with no changes in BP. In the Type B patient, 
however, PR increased initially and became erratic 
subsequently but did not increase in association with the fall 
in BP near the end of dialysis session. 
 
Contractility and Balance of Arterial and Venous Tone    
The average blood pulse inflow angle (LA - between 10 and 
90% of pulse amplitude) (Figure 15) is a measure of the 
contractility of the heart. An increase in LA indicates an 
increase in the contractility of the heart. LA of the Type A 
patient increases slightly during most of the dialysis period. 
LA is more varied for the Type B patient and decreases at 
150 min showing a reduction in contractility at that point in 
time.  
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Figure 15: Patient Type A and B’s average blood pulse inflow 
angle vs. elapsed time. 
 
Arteriolar tone is expressed as the Dicrotic Index (DCI - 
Figure 16A) and is defined as the ratio of the maximum 
amplitude of the post-dicrotic segment of the impedance 
pulse waveform to the maximum amplitude of the pulse 
(17). Venular tone is given as the Diastolic Index ( DSI - 
Figure 16B)  and is defined as the pulse amplitude at the 
time of the dicrotic notch to the maximum amplitude of the 
pulse (18). DCI and DSI indicate the response of the local 
vascular bed in the calf segment during dialysis. 
Figure 16A shows that there is a marked increase in 
arteriolar tone for Patient B while that of Patient A remains 
constant during dialysis. 
The venular tone responses of the two patients (Figure 
16B) are similar to the arteriolar tone responses; venular 
tone remained constant for patient A and increased for 
Patient B.  
 
Discussion 
The BIS system demonstrates the relative volume in each 
fluid volume compartment, namely, intracellular (Vc), 
interstitial (Vi), and intravascular (Vb). Moreover, we 
demonstrated fluid movement during hemodialysis in which 
there was net fluid removed from the human body. We 
observed two distinct patterns that patients experience. 
Pattern type A represents a hemodialysis treatment in 
which the patient did not suffer any hypotensive symptoms. 
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Figure 16A: Patient Type A and B’s arteriolar tone vs. elapsed time. 
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Figure 16B: Patient Type A and Bs venular tone vs. elapsed time. 
 
The intravascular compartment was able to refill its fluid 
volume with that from the interstitial compartment.  On the 
other hand, pattern type B represents a symptomatic 
hemodialysis treatment in which the patient experienced 
low blood pressure, tachycardia, cramps, and lightheaded-
ness. In this situation, the intravascular compartment was 
unable to refill with fluid volume and the patient became 
hypotensive.  
BIS also showed an increase in intracellular volume (Vc) 
while fluid was removed from the Type A patient. We 
speculated that the fluid originated from the extracellular 
compartments (Vi and Vb)  (Figure 10A). The Type B patient 
was not able to tolerate fluid removal. The intracellular and 
interstitial fluid volume did not change significantly. Total 
body fluid removal originated from the intravascular 
compartment (Vb) (Figure 10B). 
The BIS system reliably monitors the continuous and real 
time rates of change of the fluid volumes of the three 
compartments. The BIS intravascular volume changes 
correlate with the simultaneously measured changes in 
hematocrit (as the index of blood volume change). 
During dialysis, progressive removal of fluid with UF in 
Patient A was associated with no change in systemic arterial 
pressure but a marked increase in arteriolar tone. By 
contrast, a similar rate of fluid removal resulted in a marked 
fall in arterial pressure with no change in arteriolar tone in 
Patient B. This lack of an increase in arteriolar tone during   
fluid removal may be related to impaired arteriolar 
constriction due to decreased sympathetic nervous activity, 
commonly found in diabetic patients with autonomic 
neuropathy.  
 
 
Montgomery et al.: A system to monitor segmental changes during hemodialysis. J Electr Bioimp, 8, 40-53, 2017 
51 
 
 There are several important physiological considerations 
regarding fluid volume changes during HD. The changes in 
intravascular volume during HD are primarily a function of 
the rate of fluid removal or ultrafiltration (UF) and the 
patient's vascular refilling of fluid from the extravascular 
space. During HD, the fluid removed by UF comes directly 
from the intravascular compartment. This fluid derives from 
both the intravascular and the interstitial compartments 
and, in some cases, from the intracellular fluid space. This 
implies a continuous refilling of fluid from the extravascular 
to the vascular compartment as a compensatory mechanism 
to minimize huge reductions in circulating blood volume, 
which if left unchecked leads to “overt hypovolemia”. This, in 
turn, often results in low blood pressure during dialysis or 
“intradialytic hypotension”, the most common complication 
of dialysis that is associated with increased morbidity and 
mortality. The plasma refilling rate can be simply calculated 
as the difference between the total fluid loss and plasma 
volume loss per unit time.  
The most frequent complication of HD is hypotension as 
exemplified in Patient B in the present study. In this patient, 
intradialytic hypotension developed near the end of an HD 
session, as fluid is being removed at a steady rate by UF 
(vide supra).  Of particular interest pertains to the simultane-
ously measured BIS showing a progressive decline in 
vascular volume, which reached its climax toward the end 
(130-180 min) of HD session, while both interstitial and 
intracellular volumes remained relatively stable. These 
findings can be explained as follows. During HD, continuous 
removal of fluid from the vascular compartment results in 
progressive decline in plasma volume perhaps because of 
insufficient or impaired vascular refilling.  As a consequence, 
the interstitial volume changes little and the progressive 
decline in plasma volume in the absence of vascular refilling 
will ultimately result in intradialytic hypotension due to 
impaired vasoconstriction from autonomic dysfunction.   
By contrast, Patient A did not develop intradialytic 
hypotension and blood pressures remained relatively stable 
throughout the entire HD session with the same UF rate of 
about 1L/ hour as in patient B. However, the measured BIS 
showed that the initial decline in vascular volume during HD 
was temporally accompanied by a proportionate decrease in 
interstitial volume with only a small decrease in blood 
pressure.  In this case, it is possible a proportionate amount 
of vascular refilling occurred despite the same rate of UF 
removal, which may have preserved circulating blood 
volume and hence prevented the development of intra-
dialytic hypotension. 
These findings have several important therapeutic 
implications. During HD, circulating blood volume, a key 
determinant of blood pressure, may variably change as a 
result of ultrafiltration depending upon fluid volume shifts 
between intravascular and extravascular (interstitial and 
intracellular) compartments. The ability to accurately 
measure these changes during HD plays a central role to 
prescribing volume removal and control that will improve 
tolerance and avoid hypotension and other symptoms 
associated with hypotension. They also indicate that the 
system described above may find useful application in other 
clinical or research investigations. 
Limitations of the study include: 
1) We have used conventional R/C components in our 
revised equivalent circuit analysis model. This was done 
to ensure that our current representation would be 
completely compatible with our previous BIS analytical 
procedures. As explained in the Background section of 
this article, we use an ancillary cell model in our work 
that allows for cellular expansion and contraction. 
Inclusion of a ‘constant phase element’ in future 
equivalent circuit models may improve results from 
studies of this type. 
2) A presumption that the intercompartmental fluid shifts 
in the limb during HD reflect total body fluid shifts. 
3) Validation with the Critline.   
 
This study demonstrates for the first time that the BIS 
method can reliably provide real-time continuous 
measurements of compartmental intravascular, interstitial, 
and intracellular fluid volume and cardiovascular changes 
that occur during HD treatment. Such information may 
prove valuable in the diagnosis and management of rapid 
changes in body fluid balance. Furthermore, BIS measure-
ments can be used to predict who will have a symptomatic 
hemodialysis treatment with hypotension. As a result, the 
dialysis treatment could be adjusted accordingly so patient 
will not have hypotensive symptoms. 
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